Drug Information

Drug General Information
Drug ID
D08LDB
Former ID
DCL000405
Drug Name
GSK1265744
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [548866]
Company
GSK
Structure
Download
2D MOL

3D MOL
Formula
C19H17F2N3O5
Canonical SMILES
CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F<br />)F)O
InChI
1S/C19H17F2N3O5/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27)/t9-,14+/m0/s1
InChIKey
WCWSTNLSLKSJPK-LKFCYVNXSA-N
PubChem Compound ID
54713659
PubChem Substance ID
17424254, 36462227, 76221742, 138088923, 162108745, 174502414, 198940204, 198993890, 226461534, 244829189, 249732325
Target and Pathway
Target(s) HIV integrase Target Info Inhibitor [550963]
References
Ref 548866Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029709)
Ref 550963Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.